Acquisitions9 Jan 2026, 02:40 pm
Anlon Healthcare Completes 67.48% Acquisition of Apiqo Organics
AI Summary
Anlon Healthcare Ltd has successfully completed the acquisition of 67.48% equity shareholding of Apiqo Organics Private Limited (formerly known as M/s Apple Life Science, a partnership firm) as per the Share Purchase Agreement dated December 2, 2025. This acquisition makes Apiqo Organics a subsidiary of Anlon Healthcare Limited and is in compliance with Section 179 (3) (e) & (j) and all other applicable provisions of Companies Act, 2013. The investment details were previously disclosed on December 2, 2025, in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Key Highlights
- Anlon Healthcare Ltd acquires 67.48% equity shareholding of Apiqo Organics Private Limited.
- Apiqo Organics becomes a subsidiary of Anlon Healthcare Limited post-acquisition.
- The acquisition is in compliance with Section 179 (3) (e) & (j) and all other applicable provisions of Companies Act, 2013.
- Investment details were disclosed on December 2, 2025, as per SEBI regulations.
- The acquisition is expected to bolster Anlon Healthcare's market presence and operations.